UBC Medical Indonesia Tbk. vs Nusa Palapa Gemilang Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Nusa Palapa Gemilang Tbk. trades at Rp57 (market cap 187.93B, 25.53M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 3.1× Nusa Palapa Gemilang Tbk.'s market cap, and Nusa Palapa Gemilang Tbk. is more actively traded (25.53M versus 3.48M). Which is the better fit depends on your goals.
| LABS | NPGF | |
|---|---|---|
Market Cap | 576.7B | 187.93B |
Volume | 3.48M | 25.53M |
Lot | 34.82K | 255.25K |
Turnover | 522.79M | 1.46B |
Average Price | 150.13 | 57.27 |
Value | 522.79M | 1.46B |
Indicative Equilibrium Price | 148 | 57 |
Indicative Equilibrium Volume | 350 | 2.41K |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Nusa Palapa Gemilang Tbk (the Company) was established based on Notarial Deed No. 111 of Untung Darmosoewirjo S.H., dated November 29, 2001, a Notary in Surabaya.
Read more on NPGF →